Overview

Gender

male

Mr. Covino joined Novavax in November 2020 as executive vice president and chief financial officer with responsibility for financial strategy, performance and reporting and corporate funding. Prior to joining Novavax, Mr. Covino was group chief financial officer at GlaxoSmithKline’s TESARO Oncology Division, where he also served as senior vice president and chief accounting officer. He previously served as chief accounting officer at Biogen Inc. as well as vice president, corporate internal audit and control and vice president, international finance for Boston Scientific. Earlier in his career, Mr. Covino spent 10 years at international accounting and consulting firm PricewaterhouseCoopers. He holds a Bachelor of Science in Business Administration from Bryant University.